Copyright
©The Author(s) 2026.
Artif Intell Gastroenterol. Jan 8, 2026; 7(1): 115054
Published online Jan 8, 2026. doi: 10.35712/aig.v7.i1.115054
Published online Jan 8, 2026. doi: 10.35712/aig.v7.i1.115054
Table 1 Summarizes the previously reported reports on duodenal gastrointestinal stromal tumors
| Ref. | Year | Presenting symptoms | Key findings |
| Shanker et al[1] | 2024 | GI bleeding, obstructive jaundice | GISTs are rare, accounting for 3%-5% of duodenal cases. GISTs can present with symptoms like GI bleeding and jaundice |
| Yang et al[18] | 2025 | Fatigue, melena | GISTs in children are often asymptomatic but can present with fatal GI bleeding; initial misdiagnosis can occur |
| Amin et al[14] | 2024 | Melena, anemia | A duodenal GIST mimicking other conditions, emphasizes importance of considering GIST in differential diagnosis of duodenal lesions |
| Marques-Antunes et al[17] | 2024 | Not specified | Pathological complete response after neoadjuvant imatinib therapy in recurrent duodenal GIST, highlighting molecular testing |
| Fournier et al[15] | 2024 | Duodenal mass | Duodenal GNET can mimic GISTs; early recognition is essential due to poor prognosis and its ability to metastasize |
- Citation: Agrawal H, Dwivedi G, Rohitaj R, Tanwar H, Maurya S, Gupta N. Integrating artificial intelligence in the diagnostic pathway of duodenal gastrointestinal stromal tumors: A case report. Artif Intell Gastroenterol 2026; 7(1): 115054
- URL: https://www.wjgnet.com/2644-3236/full/v7/i1/115054.htm
- DOI: https://dx.doi.org/10.35712/aig.v7.i1.115054
